Overview
In 2020, a study published in Molecular Medicine Reports proposed a promising molecular mechanism for suppressing colorectal cancer (CRC). The research suggested that MicroRNA-628-5p (miR-628-5p) could inhibit cell proliferation and induce apoptosis by downregulating the expression of Cyclin D1 (CCND1). However, this study has since been formally retracted due to significant concerns regarding data integrity and duplication.
The Original Scientific Claim
Colorectal cancer remains a major global health challenge, driving the search for novel therapeutic targets. The authors of the now-retracted study focused on miR-628-5p, a small non-coding RNA. Their hypothesis centered on the regulation of CCND1, a critical protein that facilitates cell cycle progression.
Theoretically, by targeting CCND1, miR-628-5p would act as a tumor suppressor, slowing the rapid growth of cancer cells and triggering programmed cell death (apoptosis). While the biological premise is consistent with established oncology models, the specific evidence provided in this paper has been invalidated.
The Basis for Retraction: Data Duplication
The retraction was prompted by a "concerned reader" who identified striking similarities between the flow cytometric assay data in the paper and data appearing in unrelated articles by different authors. Specifically, Figures 2E and 5E were flagged as contentious.
Flow cytometry is a cornerstone of cancer research, used to quantify cell cycle stages and apoptosis levels. The discovery that these plots were either previously published or under consideration elsewhere prior to this study's submission suggests a systemic breach of research ethics, often associated with "paper mill" activity.
Integrity and Accountability
When the Editorial Office of Molecular Medicine Reports reached out to the authors for an explanation regarding the duplicated data, they received no reply. In academic publishing, the failure to provide raw data or explain discrepancies in the face of integrity concerns typically leads to a mandatory retraction.
This case highlights several key aspects of modern scientific publishing:
- Post-Publication Scrutiny: The role of the "concerned reader" is vital. Community-led scrutiny has become essential for maintaining the accuracy of the scientific record.
- Institutional Challenges: The fact that duplicated data bypassed initial peer review underscores the need for more robust automated screening tools for image and data duplication during the submission phase.
- Data Transparency: To prevent such occurrences, many journals now mandate the submission of raw, uncropped data files to ensure authenticity.
Conclusion
The retraction of "MicroRNA-628-5p inhibits cell proliferation and induces apoptosis in colorectal cancer through downregulating CCND1 expression levels" serves as a cautionary tale. While the miR-628-5p/CCND1 axis may still be a valid area of inquiry, the findings of this specific 2020 study are no longer considered reliable. Researchers are advised to disregard these results and look toward verified literature for foundational data in CRC therapy development.
Reference: Molecular Medicine Reports 21: 1481-1490, 2020; DOI: 10.3892/mmr.2020.10945
Summary updated